You are here

Science Behind Commonly Used Antidepressants Appears to Be Backwards, Researchers Say

Expert claims acute SSRI treatment worsens symptoms

The science behind many antidepressant medications appears to be backwards, say the authors of a paper that challenges the prevailing ideas about the nature of depression and some of the world’s most commonly prescribed medications.

The authors of the paper, published online in Neuroscience & Biobehavioral Reviews, reviewed existing research for evidence to support the theory that has dominated nearly 50 years of depression research: that depression is related to low levels of serotonin in the gaps between cells in the brain.

The low-serotonin theory is the basis for the use of selective serotonin reuptake inhibitors (SSRIs), which keep the neurotransmitter’s levels high by blocking its reabsorption into the cells that release it.

Serotonin-boosting medications actually make it harder for patients to recover, especially in the short term, according to lead author Dr. Paul Andrews of McMaster University in Ontario, Canada.

“It’s time we rethink what we are doing,” Andrews said. “We are taking people who are suffering from the most common forms of depression, and instead of helping them, it appears we are putting an obstacle in their path to recovery.”

When depressed patients treated with SSRIs do improve, it appears that their brains are actually overcoming the effects of antidepressant medications, rather than being assisted directly by them, Andrews says. Instead of helping, the medications appear to be interfering with the brain’s own mechanisms of recovery.

“We’ve seen that people report feeling worse, not better, for their first two weeks on anti-depressants,” Andrews remarked. “This could explain why.”

It is currently impossible to measure exactly how the brain is releasing and using serotonin, the researchers write, because there is no safe way to measure it in a living human brain. Instead, scientists must rely on measuring evidence about levels of serotonin that the brain has already metabolized, and by extrapolating from studies using animals.

The best available evidence appears to show that more serotonin is being released and used during depressive episodes, not less, the authors say. The paper suggests that serotonin helps the brain adapt to depression by reallocating its resources, giving more to conscious thought and less to areas such as growth, development, reproduction, immune function, and the stress response.

Andrews, an evolutionary psychologist, has argued in previous research that antidepressants leave patients in worse shape after they stop using them, and that most forms of depression, although painful, are natural and beneficial adaptations to stress.

Sources: McMaster University; February 17, 2015; and Neuroscience & Biobehavioral Reviews; January 24, 2015.

 

Recent Headlines

Almost 64% of Patients Showed Decreased Hemoglobin A1c Levels
Lifesaving Life Foam for Battlefield, Terrorist Attacks, Trauma
Cell Reprogramming Process May Benefit Patients Prone to Severe Hypoglycemia
Beagles Beat Out Advanced Technology
Over Half of Patients Had Reduced Pain Levels of 30% or More
Spina Bifida, Cleft Lip Among Defects Caused by Antiepilectics
Study Data Indicate Drug May Provide Complete Remission in PV
Teplizumab Slows Progression to Disease by at Least Two 2 Years
First Anti-PD-1 Therapy Demonstrates Improved Overall Survival